572 related articles for article (PubMed ID: 19808576)
1. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study.
Rudd JH; Myers KS; Bansilal S; Machac J; Woodward M; Fuster V; Farkouh ME; Fayad ZA
Circ Cardiovasc Imaging; 2009 Mar; 2(2):107-15. PubMed ID: 19808576
[TBL] [Abstract][Full Text] [Related]
2. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
[TBL] [Abstract][Full Text] [Related]
3. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI.
Fernández-Friera L; Fuster V; López-Melgar B; Oliva B; Sánchez-González J; Macías A; Pérez-Asenjo B; Zamudio D; Alonso-Farto JC; España S; Mendiguren J; Bueno H; García-Ruiz JM; Ibañez B; Fernández-Ortiz A; Sanz J
J Am Coll Cardiol; 2019 Apr; 73(12):1371-1382. PubMed ID: 30922468
[TBL] [Abstract][Full Text] [Related]
4. Correlation between arterial FDG uptake and biomarkers in peripheral artery disease.
Myers KS; Rudd JH; Hailman EP; Bolognese JA; Burke J; Pinto CA; Klimas M; Hargreaves R; Dansky HM; Fayad ZA
JACC Cardiovasc Imaging; 2012 Jan; 5(1):38-45. PubMed ID: 22239891
[TBL] [Abstract][Full Text] [Related]
5. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.
Duivenvoorden R; Mani V; Woodward M; Kallend D; Suchankova G; Fuster V; Rudd JHF; Tawakol A; Farkouh ME; Fayad ZA
JACC Cardiovasc Imaging; 2013 Oct; 6(10):1087-1094. PubMed ID: 24135322
[TBL] [Abstract][Full Text] [Related]
6. Should vascular wall
Lensen KDF; Voskuyl AE; Comans EFI; van der Laken CJ; Boellaard R; Smulders YM
Int J Cardiovasc Imaging; 2020 Mar; 36(3):545-551. PubMed ID: 31898005
[TBL] [Abstract][Full Text] [Related]
7. The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial.
Boczar KE; Shin S; deKemp RA; Dowlatshahi D; Tavoosi A; Wiefels C; Liu P; Lochnan H; MacPherson PA; Chong AY; Torres C; Leung E; Tawakol A; Ahmadi A; Garrard L; Lefebvre C; Kelly C; MacPhee P; Tilokee E; Raggi P; Wells GA; Beanlands R
BMJ Open; 2023 Nov; 13(11):e074463. PubMed ID: 37949621
[TBL] [Abstract][Full Text] [Related]
8. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
[TBL] [Abstract][Full Text] [Related]
9. Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
Jezovnik MK; Zidar N; Lezaic L; Gersak B; Poredos P
Inflammation; 2014 Apr; 37(2):426-34. PubMed ID: 24282108
[TBL] [Abstract][Full Text] [Related]
10. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries.
Silvera SS; Aidi HE; Rudd JH; Mani V; Yang L; Farkouh M; Fuster V; Fayad ZA
Atherosclerosis; 2009 Nov; 207(1):139-43. PubMed ID: 19467659
[TBL] [Abstract][Full Text] [Related]
11. Comparison of atherosclerotic inflammation and calcification in subjects with end stage renal disease (ESRD) on hemodialysis to normal controls utilizing
Bural GG; Torigian DA; Sözmen M; Houseni M; Alavi A
Hell J Nucl Med; 2018; 21(3):169-174. PubMed ID: 30411726
[TBL] [Abstract][Full Text] [Related]
12. Thresholds for Arterial Wall Inflammation Quantified by
van der Valk FM; Verweij SL; Zwinderman KA; Strang AC; Kaiser Y; Marquering HA; Nederveen AJ; Stroes ES; Verberne HJ; Rudd JH
JACC Cardiovasc Imaging; 2016 Oct; 9(10):1198-1207. PubMed ID: 27639759
[TBL] [Abstract][Full Text] [Related]
13. A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography.
deGoma EM; Salavati A; Shinohara RT; Saboury B; Pollan L; Schoen M; Torigian DA; Mohler ER; Dunbar RL; Litt HI; Woo J; Rader DJ; Alavi A; Mehta NN
Acad Radiol; 2015 May; 22(5):600-9. PubMed ID: 25708866
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.
Mizoguchi M; Tahara N; Tahara A; Nitta Y; Kodama N; Oba T; Mawatari K; Yasukawa H; Kaida H; Ishibashi M; Hayabuchi N; Harada H; Ikeda H; Yamagishi S; Imaizumi T
JACC Cardiovasc Imaging; 2011 Oct; 4(10):1110-8. PubMed ID: 21999871
[TBL] [Abstract][Full Text] [Related]
15. Cohort profile: BIOVASC-late, a prospective multicentred study of imaging and blood biomarkers of carotid plaque inflammation and risk of late vascular recurrence after non-severe stroke in Ireland.
McCabe JJ; Giannotti N; McNulty J; Collins S; Coveney S; Murphy S; Barry M; Harbison J; Cronin S; Williams D; Horgan G; Dolan E; Cassidy T; McDonnell C; Kavanagh E; Foley S; O'Connell M; Marnane M; Kelly P
BMJ Open; 2020 Jul; 10(7):e038607. PubMed ID: 32690537
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770
[TBL] [Abstract][Full Text] [Related]
17. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
Emami H; Vucic E; Subramanian S; Abdelbaky A; Fayad ZA; Du S; Roth E; Ballantyne CM; Mohler ER; Farkouh ME; Kim J; Farmer M; Li L; Ehlgen A; Langenickel TH; Velasquez L; Hayes W; Tawakol A
Atherosclerosis; 2015 Jun; 240(2):490-6. PubMed ID: 25913664
[TBL] [Abstract][Full Text] [Related]
18. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.
Tawakol A; Migrino RQ; Bashian GG; Bedri S; Vermylen D; Cury RC; Yates D; LaMuraglia GM; Furie K; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
J Am Coll Cardiol; 2006 Nov; 48(9):1818-24. PubMed ID: 17084256
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease.
Rominger A; Saam T; Wolpers S; Cyran CC; Schmidt M; Foerster S; Nikolaou K; Reiser MF; Bartenstein P; Hacker M
J Nucl Med; 2009 Oct; 50(10):1611-20. PubMed ID: 19759117
[TBL] [Abstract][Full Text] [Related]
20. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
